Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedSci Healthcare HoldingsHKSE:02415 79 PB Ratio is 0.31 as of Jul. 30, 2026, which is 44% below its 10-year median of 0.55. GuruFocus rates HKSE:02415 with a GF Score™ of 79/100 and a GF Value™ of HK$1.44 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 608 Healthcare Providers & Services companies, MedSci Healthcare Holdings ranks better than 97.53% on this metric.
The historical rank and industry rank for MedSci Healthcare Holdings's PB Ratio or its related term are showing as below:
HKSE:02415'
s PB Ratio Range Over the Past 10 Years
Min: 0.26 Med: 0.55 Max: 1.76
Current: 0.31
During the past 6 years, MedSci Healthcare Holdings's highest PB Ratio was 1.76. The lowest was 0.26. And the median was 0.55.
HKSE:02415's PB Ratio is ranked better than 97.53% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 2.04
vs HKSE:02415: 0.31
During the past 12 months, MedSci Healthcare Holdings's average Book Value Per Share Growth Rate was 3.20% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of MedSci Healthcare Holdings was 81.30% per year. The lowest was 81.30% per year. And the median was 81.30% per year.
Back to Basics: PB Ratio
MedSci Healthcare Holdings (HKSE:02415) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
MedSci Healthcare Holdings PB Ratio Related Terms
MedSci Healthcare Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02415 vs VEEV, BTSG, HQY: PB Ratio Comparison
For the Health Information Services subindustry, MedSci Healthcare Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedSci Healthcare Holdings PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedSci Healthcare Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where MedSci Healthcare Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
MedSci Healthcare Holdings (HKSE:02415) has a PB Ratio of 0.31 as of Jul. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MedSci Healthcare Holdings and its competitors. This is 44% below median its historical median of 0.55. Over the past decade, MedSci Healthcare Holdings' PB Ratio has ranged from 0.26 to 1.76. According to the industry distribution chart, MedSci Healthcare Holdings ranks #15 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 2.5%.
Is MedSci Healthcare Holdings' PB Ratio too high?
MedSci Healthcare Holdings' current PB Ratio of 0.31 is 44% below median its 10-year median of 0.55. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 1.76. The Healthcare Providers & Services industry median PB Ratio is 2.04. MedSci Healthcare Holdings' value of 0.31 is 84.8% below this industry median. Based on the distribution chart, MedSci Healthcare Holdings ranks #15 out of 608 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MedSci Healthcare Holdings has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MedSci Healthcare Holdings' PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedSci Healthcare Holdings ranks #15 out of 608 companies for PB Ratio. This places MedSci Healthcare Holdings in the top 3% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.04. MedSci Healthcare Holdings' value of 0.31 is 84.8% below this benchmark. Historically, MedSci Healthcare Holdings' own PB Ratio has ranged from 0.26 to 1.76 over the past decade. While the company's 10-year median is 0.55 vs. the industry median of 2.04, MedSci Healthcare Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.04, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedSci Healthcare Holdings's current PB Ratio of 0.31 is 84.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MedSci Healthcare Holdings and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedSci Healthcare Holdings's current PB Ratio is 0.31, which is 44% below median its own 10-year median of 0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedSci Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, MedSci Healthcare Holdings (HKSE:02415) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.44, compared to a current price of HK$0.73 — trading 49.3% below its estimated fair value. The current PB Ratio is 0.31, which is 44% below median its 10-year median of 0.55 and 84.8% below the Healthcare Providers & Services industry median of 2.04. MedSci Healthcare Holdings' overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For MedSci Healthcare Holdings (HKSE:02415), the current PB Ratio is 0.31 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedSci Healthcare Holdings (HKSE:02415) Overvalued in 2026?
Based on GuruFocus' analysis, MedSci Healthcare Holdings stock appears to be undervalued.
The current stock price of HK$0.73 is trading 49.3% below its estimated GF Value™ of HK$1.44.
GuruFocus considers MedSci Healthcare Holdings to be Possible Value Trap.
Key valuation signals for HKSE:02415:
PB Ratio: 0.31 (44% below median its 10-year median of 0.55)
GF Value™: HK$1.44 vs. price of HK$0.73 (49.3% below fair value)
Industry Position: 84.8% below the Healthcare Providers & Services median (#15 of 608)
No single metric tells the full story. See the HKSE:02415 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedSci Healthcare Holdings Ltd is an investment holding company. It operates online professional physician platforms in China. The principal activities of the company are the provision of physician platform solutions, precision omni-channel marketing solutions, and real-world study solutions in the People's Republic of China.
79GF Score
Get the complete analysis for HKSE:02415
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02415 has been successfully added to your 
